Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZR4 vs Insulin Icodec in Type 2 Diabetes
NCT07165223Phase 3Recruiting
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Oct 2025
- Primary completion
- Nov 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of GZR4 in type 2 diabetes mellitus (T2DM), sponsored by Gan & Lee Pharmaceuticals. Started Oct 2025; status: recruiting.
02
Drugs
GZR4
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07165223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07165223.